NCT04751383 · Interventional trial
Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma
Overall registry status Terminated
Phase 1
Conditions High Risk Neuroblastoma, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Refractory Neuroblastoma, Resectable Osteosarcoma
Delaware Valley sites
- Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory